TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Visiopharm LRI AB
Closing information (x1000 SEK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
20,531
|
24,999 | |
| Financial expenses |
0
|
1 | |
| Earnings before taxes |
883
|
2,358 | |
| EBITDA |
750
|
2,358 | |
| Total assets |
20,314
|
15,517 | |
| Current assets |
20,300
|
15,517 | |
| Current liabilities |
10,133
|
5,819 | |
| Equity capital |
9,920
|
9,235 | |
| - share capital |
100
|
100 | |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
48.8%
|
59.5% | |
| Turnover per employee |
6,844
|
8,333 | |
| Profit as a percentage of turnover |
4.3%
|
9.4% | |
| Return on assets (ROA) |
4.3%
|
15.2% | |
| Current ratio |
200.3%
|
266.7% | |
| Return on equity (ROE) |
8.9%
|
25.5% | |
| Change turnover |
-4,468
|
-4,265 | |
| Change turnover % |
70%
|
-18%
|
-15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.